Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Relmada Therapeutics Inc shares valued at $86,735 were purchased by TRAVERSA SERGIO on Aug 27 ’25. At $0.67 per share, TRAVERSA SERGIO acquired 129,455 shares. The insider’s holdings grew to 944,024 shares worth approximately $0.73 million following the completion of this transaction.
Also, TRAVERSA SERGIO purchased 80,545 shares, netting a total of over 49,938 in proceeds. Following the buying of shares at $0.62 each, the insider now holds 814,569 shares.
Before that, TRAVERSA SERGIO had added 55,976 shares to its account. In a trade valued at $41,422, the Chief Executive Officer bought Relmada Therapeutics Inc shares for $0.74 each. Upon closing the transaction, the insider’s holdings increased to 55,976 shares, worth approximately $0.77 million.
As published in a research note from Mizuho on December 05, 2024, Relmada Therapeutics Inc [RLMD] has been rated down from an Outperform to a Neutral and the price target has been revised to $1 from $23. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid September. As of June 05, 2024, Goldman has decreased its “Neutral” rating to a “Sell” for RLMD. Earlier on October 14, 2022, Truist downgraded its rating. Their new recommendation was “a Hold” for RLMD stock which previously was a “a Buy”.
Analyzing RLMD Stock Performance
On last trading session, Relmada Therapeutics Inc [NASDAQ: RLMD] rose 15.76% to $0.77. The stock’s lowest price that day was $0.6303, but it reached a high of $0.8192 in the same session. During the last five days, there has been a surge of approximately 27.05%. Over the course of the year, Relmada Therapeutics Inc shares have dropped approximately -72.32%. Shares of the company reached a 52-week high of $0.9000 on 06/06/25 and a 52-week low of $0.2404 on 03/03/25.
Support And Resistance Levels for Relmada Therapeutics Inc (RLMD)
According to the 24-hour chart, there is a support level at 0.6636, which, if violated, would cause prices to drop to 0.5521. In the upper region, resistance lies at 0.8532. The next price resistance is at 0.9313. RSI (Relative Strength Index) is 68.87 on the 14-day chart, showing neutral technical sentiment.
Is Relmada Therapeutics Inc subject to short interest?
Stocks of Relmada Therapeutics Inc saw a sharp rise in short interest on 2025-08-15 jumping by 54481.0 shares to 0.48 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 0.42 million shares. A jump of 11.39% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.32 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.32.
Which companies own the most shares of Relmada Therapeutics Inc (RLMD)?
In terms of Relmada Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 7 in the next 12 months, up nearly 944.78% from the previous closing price of $0.67. Analysts anticipate Relmada Therapeutics Inc stock to reach 8 by 2025, with the lowest price target being 2. In spite of this, 1 analysts ranked Relmada Therapeutics Inc stock as Sell at the end of 2025.
